Research & Development

UCB's goal is to command a leading position in discovering and developing new therapies to treat patients suffering from severe diseases. With a strong pipeline, our focus is on central nervous system (CNS) disorders and immunology diseases to provide new treatments for specialists and their patients.

Our key features

Patients are at the heart of all we do, driving our commitment to the treatment of severe diseases
A focus on these therapeutic areas: central nervous system (CNS) and immunology
An international R&D organization comprised of UCB New Medicines^TM and UCB Global Projects and Development
A track record of successful partnerships with both academia and leading drug discovery organizations. Partnership is part of our philosophy

One UCB approach

Our philosophy is to have a "one team" approach to drug discovery and development with seamless integration of research, development and commercial colleagues, in a process of continual learning and confirming as we examine our data and capitalize on our knowledge.

More information on UCB global research and development on the
UCB Corporate Web site.